2型糖尿病口服药的心血管获益与风险

Cardiovascular benefits and risks in oral antidiabetic treatment of type 2 diabetes

糖尿病在血糖、血压、血脂控制不佳的情况下是心血管疾病的等危症。临床医生应用罗格列酮降糖时,仍要考虑它的潜在不良心血管事件。提示我们应进一步关注降糖药物的心血管安全性。

Type 2 diabetes was a ＂coronary heart disease equivalent＂ in codition of hyperglycemia, hypertension and hyperlipemia. The potential cardiovascular adverse events of using rosiglitazone to reduce blood sugar should be taken into account. As clinicians, we should pay more attention to the cardiovascular safety of antidiabetic drugs.